3 Stocks Investors Are Screening After The Midterm Shift In Healthcare And Solar

Democrats’ midterm win has jolted U.S. markets, with indexes and policy sensitive sectors moving sharply as investors reassess the rules of the game. Political clarity often reshuffles where capital flows next, and moments like this can leave careful investors either comfortably ahead or watching from the sidelines. This article unpacks three stocks exposed to the latest policy shifts and shows how the same news can create very different stories.

The three companies highlighted next are a starting sample, since the full screen surfaced 7 more U.S. solar and Medicaid or ACA exposed insurers with equally detailed stories that are not covered here.

If you want to identify and analyze potential policy beneficiaries side by side, head straight into the U.S. Solar and Medicaid/ACA-Exposed Healthcare Insurers screener.

AdaptHealth (AHCO)

AdaptHealth sits in this policy focused screen because it supplies home medical gear to patients funded by Medicare, Medicaid, and commercial plans, so shifts in publicly backed coverage can influence how much kit flows through its network.

AdaptHealth runs a U.S. based home medical equipment and services platform. Sleep Health generates about US$1.5b, Respiratory Health roughly US$700 million, Wellness At Home around US$600 million, and there is a segment adjustment of about US$600 million, with the stock valued near US$800 million in market cap.

"Analyst commentary has typically framed AdaptHealth’s digital automation and AI projects as tools to defend margins, but the myAPP platform now reaching 512,000 users with strong engagement, together with an AI mask fitting feature that is converting 92% of scans into completed orders and reducing refits, points to a wider opportunity for structurally higher net margins and operating leverage as more order intake and servicing shift to these lower cost channels."

The real swing factor is how a single pressure on its contract economics plays out against that push toward leaner, tech driven operations.

That tension is exactly what the full narrative for AdaptHealth unpacks, separating short term reimbursement friction from the areas where AdaptHealth’s margin structure could be quietly decoupling from old constraints.

Montauk Renewables (MNTK)

Montauk Renewables fits this clean-energy themed screen through its focus on turning landfill and agricultural methane into renewable gas and power. The key question for investors is how its shift in revenue mix is reshaping both risk and reward.

Montauk Renewables develops, owns, and operates projects that capture methane from landfills and other non fossil fuel sources in the United States, converting it into renewable natural gas and electricity. Around US$155 million comes from Renewable Natural Gas, about US$17 million from Renewable Electricity Generation, plus a US$16 million segment adjustment, with the stock valued near US$345 million in market cap.

"The move by Montauk Renewables away from fixed lower-price RNG contracts toward higher exposure to self-marketed RIN volumes, with a reported 80% fall in fixed lower-price contract volumes in Q2 2026 alongside a more than 25% rise in self-marketed RIN volumes, leaves a larger share of future revenue and earnings tied to environmental attribute pricing that the current valuation already seems to assume will remain supportive."

Investors may also want to consider what could happen if a single pressure on those underlying credit markets pulls this carefully balanced growth story in a less comfortable direction.

That pressure point is exactly where the story could accelerate or stall. Read the full narrative for Montauk Renewables to see how Montauk Renewables’ contract mix might be masking bigger long term shifts.

Astrana Health (ASTH)

Astrana Health plugs into this policymaker focused screen through its managed-care style model, coordinating medical services for Medicare, Medicaid and commercially insured patients across the U.S. while generating about US$3.6b from Care Partners, roughly US$339 million from Care Delivery, US$340 million from Care Enablement and carrying a market value near US$1.9b.

For investors tracking how policy friendly sentiment can ripple through managed-care heavy healthcare, Astrana Health offers a useful test case because its model leans into coordinated care and value based contracts rather than simple fee-for-service volume.

"Continued transition of Astrana Health members and contracts into full-risk arrangements, already at about 81% of capitation revenue and 42% of membership, positions the company to grow recurring revenue and keep more of the economics if medical cost trend stays slightly better than current assumptions, which can support earnings and net margin resilience."

What happens if a single unseen pressure shifts how those policy linked patient flows and contract terms balance against rising medical costs?

If that unseen pressure is what you keep circling, read the full narrative for Astrana Health to see whether Astrana Health’s risk pool is quietly masking a stronger earnings engine.

Seeking Alternatives Before The Crowd?

Fresh breakouts and momentum shifts rarely stay under the radar for long. Spot stocks flying or quietly dropping while it still matters, then get in early.

• Track cash rich companies quietly building strength by scanning the list of solid balance sheet and fundamentals (23 results) before that quality gets fully priced in.
• Target income opportunities with staying power by running through the 4 dividend fortresses while yields remain elevated and attention is still elsewhere.
• Hunt for future infrastructure winners by checking the 41 power grid technology and infrastructure stocks while these critical enablers of electrification remain under the radar for now.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com